Krystal Biotech (KRYS) Share-based Compensation (QoQ) (2016 - 2026)
Krystal Biotech (KRYS) Share-based Compensation (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.02% |
| Mar 31, 2026 | -74.19% |
| Dec 31, 2025 | 304.32% |
| Sep 30, 2025 | -282.75% |
| Jun 30, 2025 | 4.76% |
| Mar 31, 2025 | 137.68% |
| Dec 31, 2024 | -368.63% |
| Sep 30, 2024 | -40.70% |
| Dec 31, 2023 | -461.89% |
| Sep 30, 2023 | -26.64% |
| Jun 30, 2023 | 8.57% |
| Mar 31, 2023 | 9.27% |
| Dec 31, 2022 | -57.14% |
| Mar 31, 2022 | 124.13% |
| Dec 31, 2021 | -194.50% |
| Sep 30, 2021 | 50.59% |
| Dec 31, 2020 | 343.09% |
| Sep 30, 2020 | -266.79% |
| Jun 30, 2020 | 49.72% |
| Sep 30, 2019 | 1,249.21% |